Social Media Ideas for Nci:ca

<![CDATA[FDA Approves Tecentriq for Stage III dMMR Colon Cancer]]>

NTG Clarity Networks Inc. (NCI:CA) Q2 2026 Earnings Call Transcript

AcademyHealth Releases Compendium of Cancer Biomarker Initiatives: A Central Repository for Cancer Biomarker Testing Res...

AcademyHealth Releases Compendium of Cancer Biomarker Initiatives: A Central Repository for Cancer Biomarker Testing Resources AcademyHealth’s Scaling Cancer Biomarker Test...

Cancer leads AI physician queries across 9 countries

While cancer continues to be a major global health challenge, it is also a rapidly changing area of medicine. Targeted therapies, immunotherapy, genomic testing, biomarker-driven t...

ESMO 2026 Preview | Mabwell to Present Clinical Results for Nectin-4-Targeting ADC 9MW2821 in ADC-Pretreated Triple-Nega...

SHANGHAI, Oct. 18, 2026 /PRNewswire/ -- Mabwell (688062.SH, 02493.HK), an innovation-driven biopharmaceutical company with a fully integrated industry chain, will present Phase II...

CT and biomarkers support small cell lung cancer diagnosis in unbiopsied patient

A two-case report found that characteristic CT findings, markedly elevated NSE and multidisciplinary review enabled an image-supported small cell lung cancer diagnosis and treatmen...

Chemo-Resistant Pancreatic Tumor Liquefies and Drains Several Months after Receiving Proprietary Intratumoral EpCAM/CD3...

Peer-reviewed case report documents 90% volume reduction together with extensive necrosis — achieved without surgery or full-dose chemotherapy after gemcitabine failed SAN DIEGO, S...

UH Cancer Center’s Body Composition Laboratory receives designation as IAEA Collaborating Centre

The University of Hawaiʻi Cancer Center’s Body Composition Shared Resource Laboratory has been designated as an International Atomic Energy Agency (IAEA) Collaborating Centre, reco...

Updated blood-based CRC test improves APL sensitivity

NASHVILLE, Tenn. — An updated version of the blood-based SimpleScreen CRC screening test improved detection of advanced precancerous lesions while maintaining high sensitivity for...

This Molecular Switch Helps Triple-Negative Breast Cancers Resist Treatment

Researchers uncover how the long non-coding RNA Smyca helps triple-negative breast cancer cells repair DNA damage and survive treatment.

Circular RNA Revealed as Hidden Brake on Colorectal Cancer Growth

Researchers report that the circular RNA circMTCL1, sharply depleted in colorectal cancer tumors, suppresses cancer cell growth by sponging miR-145-5p, boosting BMP3, and damping M...

Aprea Expands Development of WEE1 Inhibitor After Seeing Early Clinical Activity Signs vs. Cancer

The Phase I dose escalation trial of ACESOT-1051 (NCT06260514) will accelerate its patient enrollment, with Aprea planning to more than triple its number of active clinical sites f...

Small Cell Lung Cancer Relies on Targetable Nonsense-Mediated Decay for Immune Control

A Hidden RNA-Decay System May Be the Achilles’ Heel of Small-Cell Lung Cancer Small-cell lung cancer, one of the most aggressive forms of cancer, may depend on a cellular quality-c...

Community Hospitals May Leave Breast Cancer Patients Feeling Better Heard Than Regional Centers

A SEER-CAHPS analysis of 3,327 Medicare patients finds community-facility breast cancer surgery linked to better reported access, with care trajectories tending to stay in the same...

Metarrestin’s Anti-Cancer Mechanism Mapped Through Network Pharmacology

A new network pharmacology study maps how the anti-metastatic drug metarrestin rewires cancer cell protein networks and identifies the cell-cycle regulator CDKN1B as its highest-af...